Use the Back button in your browser to see the other results of your search or to select another record.
| The impact of World Health Organization Government of India guidelines on chronic obstructive pulmonary diseases 2003 on quality of life |
| Janmeja AK, Mohapatra PR, Kumar M |
| Lung India 2009 Oct-Dec;26(4):102-105 |
| clinical trial |
| 3/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: No. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
BACKGROUND: The World Health Organization-Government of India (WHO-GOI) Guidelines 2003 for management of chronic obstructive pulmonary diseases (COPD) is a consensus statement. However, the outcome and impact of its implementation on quality of life (QOL) among COPD patients has not been studied so far. MATERIALS AND METHODS: The patients were randomized to intervention group (n = 50) and control group (n = 40). All were treated and followed up for 6 months. A pulmonary physician reviewed patients of both the groups, at least 3 times in 6 months period. St George's Respiratory Questionnaire was measured at baseline and at 6 months. Patients in control group visited the center on a "need to" basis and were prescribed conventional treatment by the doctor on duty. RESULTS: Forty-two patients in the intervention group and 32 in the control group completed 3 visits over the period of 6 months and were included in analysis. The severity as per the guidelines was moderate in 74% and severe in 26% in intervention group while it was moderate in 64% and severe in 36% cases in control group. Follow-up QOL scores were significantly better as compared with baseline values (p < 0.001). The QOL of the patients treated according to the guidelines were significantly better (p < 0.001) than those in the control group with conventional treatment. CONCLUSION: The consensus derived recommendations of WHO-GOI Guidelines for COPD 2003 are beneficial for management of COPD patients over conventional management.
|